Healthcare provider profile · identity verified

Sean Dev Machanda, MD

Family Practice · TOLEDO, OH · NPI 1538125760

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	613	161
Amlodipine Besylate	Amlodipine Besylate	397	89
Gabapentin	Gabapentin	333	76
Pantoprazole Sodium	Pantoprazole Sodium	298	74
Metoprolol Succinate	Metoprolol Succinate	289	71
Lisinopril	Lisinopril	276	68
Levothyroxine Sodium	Levothyroxine Sodium	274	64
Omeprazole	Omeprazole	272	62
Tamsulosin Hcl	Tamsulosin Hcl	242	58
Losartan Potassium	Losartan Potassium	229	55
Rosuvastatin Calcium	Rosuvastatin Calcium	193	56
Hydrochlorothiazide	Hydrochlorothiazide	183	40
Albuterol Sulfate Hfa	Albuterol Sulfate	176	60
Trazodone Hcl	Trazodone Hcl	176	33
Metoprolol Tartrate	Metoprolol Tartrate	172	37
Montelukast Sodium	Montelukast Sodium	171	41
Metformin Hcl	Metformin Hcl	163	50
Sertraline Hcl	Sertraline Hcl	158	32
Bupropion Xl	Bupropion Hcl	148	33
Furosemide	Furosemide	143	38
Escitalopram Oxalate	Escitalopram Oxalate	138	29
Metformin Hcl Er	Metformin Hcl	123	33
Potassium Chloride	Potassium Chloride	121	36
Allopurinol	Allopurinol	120	27
Duloxetine Hcl	Duloxetine Hcl	117	23
Tizanidine Hcl	Tizanidine Hcl	117	28
Valsartan	Valsartan	117	31
Simvastatin	Simvastatin	116	28
Fluticasone Propionate	Fluticasone Propionate	111	40
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	98	23
Meloxicam	Meloxicam	96	33
Alprazolam	Alprazolam	94	22
Eliquis	Apixaban	91	26
Famotidine	Famotidine	89	31
Pregabalin	Pregabalin	86	16
Alendronate Sodium	Alendronate Sodium	85	18
Glimepiride	Glimepiride	84	24
Pravastatin Sodium	Pravastatin Sodium	83	24
Mirtazapine	Mirtazapine	80	21
Carvedilol	Carvedilol	79	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	16
Jardiance	Empagliflozin	78	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	75	16
Prednisone	Prednisone	70	38
Clopidogrel	Clopidogrel Bisulfate	66	18
Buspirone Hcl	Buspirone Hcl	62	16
Fluoxetine Hcl	Fluoxetine Hcl	59	14
Ibuprofen	Ibuprofen	58	13
Warfarin Sodium	Warfarin Sodium	58	15
Oxybutynin Chloride Er	Oxybutynin Chloride	57	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	14
Xarelto	Rivaroxaban	55	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	14
Celecoxib	Celecoxib	52	20
Clonidine Hcl	Clonidine Hcl	52	suppressed
Donepezil Hcl	Donepezil Hcl	51	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	51	14
Ozempic	Semaglutide	50	suppressed
Januvia	Sitagliptin Phosphate	49	15
Spironolactone	Spironolactone	49	15
Diclofenac Sodium	Diclofenac Sodium	48	16
Atenolol	Atenolol	47	12
Ropinirole Hcl	Ropinirole Hcl	44	11
Azelastine Hcl	Azelastine Hcl	43	21
Hydralazine Hcl	Hydralazine Hcl	43	suppressed
Tramadol Hcl	Tramadol Hcl	40	14
Ezetimibe	Ezetimibe	39	12
Primidone	Primidone	38	suppressed
Enalapril Maleate	Enalapril Maleate	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	23
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	30
Aripiprazole	Aripiprazole	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	36	suppressed
Klor-Con M20	Potassium Chloride	35	suppressed
Lansoprazole	Lansoprazole	34	suppressed
Cephalexin	Cephalexin	33	23
Farxiga	Dapagliflozin Propanediol	33	suppressed
Mounjaro	Tirzepatide	33	suppressed
Nifedipine Er	Nifedipine	33	suppressed
Baclofen	Baclofen	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	11
Memantine Hcl	Memantine Hcl	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	24
Temazepam	Temazepam	32	suppressed
Lovastatin	Lovastatin	31	suppressed
Ondansetron Odt	Ondansetron	31	15
Azithromycin	Azithromycin	30	17
Bumetanide	Bumetanide	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Lactulose	Lactulose	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Ammonium Lactate	Ammonium Lactate	28	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	22
Methylprednisolone	Methylprednisolone	27	22
Lorazepam	Lorazepam	26	suppressed
Nystatin	Nystatin	26	suppressed
Rybelsus	Semaglutide	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Galantamine Er	Galantamine Hbr	25	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	25	suppressed
Naproxen	Naproxen	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Glipizide Er	Glipizide	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Sucralfate	Sucralfate	24	12
Clonazepam	Clonazepam	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Topiramate	Topiramate	22	suppressed
Trulicity	Dulaglutide	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Risperidone	Risperidone	20	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Amoxicillin	Amoxicillin	17	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	17	suppressed
Glipizide	Glipizide	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Larin Fe	Norethindrone-E.Estradiol-Iron	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Finasteride	Finasteride	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Digoxin	Digoxin	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error